Author： Tavel J.A.
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.4, 2000-04, pp. : 917-928
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ongoing trials with matrix metalloproteinase inhibitors
By Brown P.D.
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 9, 2000-09 ,pp. :
Access to resources
Recommend
Heterocyclic HIV-Protease Inhibitors
Current Medicinal Chemistry, Vol. 20, Iss. 30, 2013-10 ,pp. :
By Kuhnert Maren Diederich Wibke E.
PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. :
Prodrugs of HIV Protease Inhibitors
Current Pharmaceutical Design, Vol. 9, Iss. 22, 2003-08 ,pp. :
Peptidomimetic Inhibitors of HIV Protease
Current Topics in Medicinal Chemistry, Vol. 4, Iss. 10, 2004-06 ,pp. :